NEW YORK (GenomeWeb) – The non-profit Transforming Medicine: The Elizabeth Kauffman Institute (TMed), which seeks to match patients with life-threatening diseases with the most appropriate treatments, officially launched today. 

Founded by Institute for Systems Biology President Lee Hood and others, Cambridge, Massachusetts-based TMed plans to develop a knowledgebase for evaluating patient information, including genetic and molecular data, to determine the best marketed and research-stage treatment for each individual. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.